Recombinant CD19 (Tafasitamab Biosimilar) 抗体 (Biotin)
Our Local Distributor
北京 101111
Quick Overview for Recombinant CD19 (Tafasitamab Biosimilar) 抗体 (Biotin) (ABIN7828992)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
质量等级
-
-
原理
- Biotinylated Anti-CD19(tafasitamab biosimilar) mAb
-
亚型
- IgG1, IgG2, kappa
-
-
-
-
说明
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Please see Certificate of Analysis for specific instructions of reconstitution.
-
缓冲液
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
-
储存条件
- -20 °C,-80 °C
-
储存方法
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
有效期
- 12 months
-
-
- CD19 (Tafasitamab Biosimilar)
-
别名
- Tafasitamab Biosimilar
-
物质类
- Biosimilar
-
背景
-
Synonyms Target:CD19,B4,CVID3,MGC12802
Synonyms Antibody:ICP-B04,ICP B04,MOR 208,MOR208,MOR-208,XENP-5574,XENP5574,XENP 5574,XmAb-5574,XmAb5574,XmAb 5574 -
UniProt
- P15391
抗原
-